Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Joinn Laboratories(China)Co.,Ltd. (603127.SS)

15.59
+0.15
+(0.97%)
As of 11:30:00 AM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,018,333.77
2,018,333.77
2,376,486.80
2,267,970.98
1,516,680.03
Cost of Revenue
1,444,560.23
1,444,560.23
1,363,701.06
1,181,659.52
777,557.99
Gross Profit
573,773.54
573,773.54
1,012,785.73
1,086,311.46
739,122.04
Operating Expense
392,434.08
392,434.08
379,146.50
369,143.36
287,179.73
Operating Income
181,339.46
181,339.46
633,639.24
717,168.10
451,942.31
Net Non Operating Interest Income Expense
99,773.21
99,773.21
139,063.22
130,510.77
83,023.53
Pretax Income
104,039.07
104,039.07
506,950.44
1,240,002.33
642,003.71
Tax Provision
34,284.01
34,284.01
115,397.88
166,802.23
85,587.39
Net Income Common Stockholders
74,075.38
74,075.38
396,992.57
1,074,257.18
557,459.61
Basic EPS
0.00
0.10
0.53
1.44
0.77
Diluted EPS
0.00
0.10
0.53
1.43
0.76
Basic Average Shares
776,528.58
740,753.85
749,042.58
746,011.93
722,632.83
Diluted Average Shares
776,528.58
740,753.85
749,042.58
751,228.80
729,386.40
Total Operating Income as Reported
104,347.31
104,347.31
507,096.32
1,225,638.85
642,889.19
Total Expenses
1,836,994.31
1,836,994.31
1,742,847.56
1,550,802.88
1,064,737.72
Net Income from Continuing & Discontinued Operation
74,075.38
74,075.38
396,992.57
1,074,257.18
557,459.61
Normalized Income
216,735.89
216,735.89
618,864.67
779,329.51
423,304.14
Interest Income
103,230.77
103,230.77
142,503.40
131,232.74
83,724.19
Interest Expense
2,448.07
2,448.07
3,055.83
351.10
420.74
Net Interest Income
99,773.21
99,773.21
139,063.22
130,510.77
83,023.53
EBIT
106,487.15
106,487.15
510,006.27
1,240,353.43
642,424.45
EBITDA
236,806.85
236,806.85
639,518.11
1,361,313.02
738,862.86
Reconciled Cost of Revenue
1,444,560.23
1,444,560.23
1,363,701.06
1,181,659.52
777,557.99
Reconciled Depreciation
130,319.70
130,319.70
129,511.84
120,959.59
96,438.41
Net Income from Continuing Operation Net Minority Interest
74,075.38
74,075.38
396,992.57
1,074,257.18
557,459.61
Total Unusual Items Excluding Goodwill
-212,776.90
-212,776.90
-287,261.97
340,766.83
154,791.13
Total Unusual Items
-212,776.90
-212,776.90
-287,261.97
340,766.83
154,791.13
Normalized EBITDA
449,583.75
449,583.75
926,780.08
1,020,546.19
584,071.74
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-70,116.40
-70,116.40
-65,389.87
45,839.16
20,635.66
12/31/2021 - 8/25/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

300347.SZ Hangzhou Tigermed Consulting Co., Ltd
45.34
-0.33%
 
IJF.MU Icon PLC
124.85
+3.22%
 
0RUG.IL bioMérieux S.A.
113.90
+0.26%
 
TN8.DE Thermo Fisher Scientific Inc.
372.55
-5.86%
 
ILU.F Illumina, Inc.
67.72
+1.38%
 
DIA.WA Diagnostyka S.A.
148.50
-2.17%
 
QIA.DE Qiagen N.V.
37.61
+0.17%
 
TN8.F Thermo Fisher Scientific Inc.
370.65
-8.22%
 
DAP.DE Danaher Corporation
172.20
-2.14%
 
DMTKQ DermTech, Inc.
0.0001
0.00%